I got an email update from the STLT CEO, the one that most of the convertible debt is owed to and one of the two insiders holding 66% of the restricted OS shares. It was amass email from him to those in the company database that signed up over the years for updates.
Basically said he and the company are still working the plan, operating, working on possible deals, drug trials, better financing and so on, and a Happy New Year wish with a thanks to faithful longs hanging in there.
Right now this is so way oversold, and way way way undervalued I am a buyer of share dumps here this low. Still under 10 Mil shares in the float. Assets were valued at something like 10-15 times the market cap today. Float is valued at $80,000 today at the best bid, for a biotech with a real OTC- pain killing rub on product selling at Walmart.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
